Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20399780 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.
Condition: Liver Disease
Intervention: Genetic: genotyping and/or sequencing
2 Withdrawn Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: telaprevir

Study has passed its completion date and status has not been verified in more than two years.